Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Estrogen therapy can reduce skin aging but has cancer risks.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Hirsutism causes significant psychological distress in women.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.